Consistent with our findings, PKC activation was reported to induce ADAM9 upregulation in NSCLC cells [45], and NF-κB signaling was shown to promote ADAM9 expression in pancreatic cancer [46]. Here, PRRT2 is linked to non-small cell lung carcinoma.